The legally binding procedures had been completed. Next came the practical implementation.
Before starting gene therapy, they first had to purchase the necessary hardware and software.
As for which suppliers to buy the hardware and software from, Shen Qi offered his suggestion. "Micro-robots, microneedles, and the accompanying operating software are all available on the market. Internationally, Germany's ART Company has the best reputation. Domestically, Huahan Gene is also Asia's best and among the world's top companies, and it's trustworthy. My purchasing recommendation is to choose either ART or Huahan Gene. If anyone has other suppliers in mind, feel free to recommend them."
Everyone voiced their agreement. "We support Director Shen's proposal to choose between the two suppliers."
"Han Meng previously purchased five million yuan's worth of basic instruments and equipment, saving our research group one or two million yuan while still getting us the best products. He really managed to accomplish a lot with a little, and did a great job. Han Meng should handle the hardware and software procurement for this gene therapy as well. You can decide which supplier to buy from and what specifications and models to get. After all, you're the lead researcher on this gene therapy experiment. The amount involved this time is fairly large, so please make sure to adhere to all anti-corruption regulations during the purchasing process. That's all I have to say. Everyone can get back to work." Shen Qi arranged the work for the biology lab, then adjourned the meeting.
The sequencing of the human genome's three billion base pairs had been completed back in 2003. Yet to this day, only 2% of it encoded the more than twenty thousand genes in the human body.
Even with only this 2% of the genome, it was technically possible to edit and modify